CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishA new analytical method, based on the use of liquid chromatography with coulometric detection, has been developed and applied to quantify risperidone and its main active metabolite9-hydroxyrisperidone in human plasma and saliva. The analytes were separatedon a reversed phase C18 column, using a mobile phase composed of acetonitrile (26%) and a pH 6.5 phosphate buffer(74%). Pipamperone was used as the internal standard. A high sensitivity coulometric detection analytical cell containing two flow-through working electrodes was used: electrode 1 was set at +0.500 V and electrode 2 at +0.700 V. The detector response was linear over a plasma and saliva concentration range of 0.5–50.0 ng mL−1 for risperidone and 0.5–100.0 ng mL−1 for 9-hydroxyrisperidone. The limit of quantitation and the limit of detection for risperidone and 9-hydroxyrisperidone were 0.5 ng mL−1 and 0.17 ng mL−1, respectively. A novel clean-up procedure of biological samples was developed using the micro extraction by packed sorbent technique, which gave good extraction yield for both the analytes, with absolute recovery values higher than 90.1%. The intra-day and the inter-day precision results, expressed by relative standard deviation values, were lower than 5.8%. Accuracy and selectivity assays were also satisfactory. The validated method has been successfully applied to the analysis of risperidone and 9-hydroxyrisperidone in plasma and saliva of psychiatric patients undergoing therapy with risperidone.
| Titolo: | Analysis of risperidone and its metabolite in plasma and saliva by LC with coulometric detection and a novel MEPS procedure | |
| Autore/i: | SARACINO, MARIA ADDOLORATA; A. de Palma; BONCOMPAGNI, GIANCARLO; RAGGI, MARIA AUGUSTA | |
| Autore/i Unibo: | ||
| Anno: | 2010 | |
| Rivista: | ||
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.talanta.2010.02.067 | |
| Abstract: | A new analytical method, based on the use of liquid chromatography with coulometric detection, has been developed and applied to quantify risperidone and its main active metabolite9-hydroxyrisperidone in human plasma and saliva. The analytes were separatedon a reversed phase C18 column, using a mobile phase composed of acetonitrile (26%) and a pH 6.5 phosphate buffer(74%). Pipamperone was used as the internal standard. A high sensitivity coulometric detection analytical cell containing two flow-through working electrodes was used: electrode 1 was set at +0.500 V and electrode 2 at +0.700 V. The detector response was linear over a plasma and saliva concentration range of 0.5–50.0 ng mL−1 for risperidone and 0.5–100.0 ng mL−1 for 9-hydroxyrisperidone. The limit of quantitation and the limit of detection for risperidone and 9-hydroxyrisperidone were 0.5 ng mL−1 and 0.17 ng mL−1, respectively. A novel clean-up procedure of biological samples was developed using the micro extraction by packed sorbent technique, which gave good extraction yield for both the analytes, with absolute recovery values higher than 90.1%. The intra-day and the inter-day precision results, expressed by relative standard deviation values, were lower than 5.8%. Accuracy and selectivity assays were also satisfactory. The validated method has been successfully applied to the analysis of risperidone and 9-hydroxyrisperidone in plasma and saliva of psychiatric patients undergoing therapy with risperidone. | |
| Data prodotto definitivo in UGOV: | 2010-12-20 11:30:22 | |
| Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
Copyright © 2021